date:Oct 31, 2018
an and animal health by promoting product innovation and applying modern, efficient and risk-based regulatory pathways; 2) strengthening public outreach and communication regarding the FDAs approach to innovative plant and animal biotechnology; and 3) increasing engagement with domestic and international partners on biotechnology issues.
Many of the priorities identified in our Action Plan are well underway. We will be seeking public input as appropriate, over the coming year, with the expectat